| POU5F1 |
bipolar neuron |
0.5 μg/mL doxycycline hyclate (CHEBI:34730) for 4 day |
Permissive
Robust
|
Homo sapiens |
ENCSR362VCG
|
MA0142.1
...
|
| POU5F1 |
CMTi-1 (embryonic stem cells) |
shH2A.Z |
Permissive
Robust
|
Mus musculus |
GSE34483
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
jmjd2b KD |
Permissive
|
Mus musculus |
GSE43229
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
jmjd2c KD |
Permissive
Robust
|
Mus musculus |
GSE43229
...
|
MA0142.1
...
|
| POU5F1 |
epiblast-like cells |
Activin A |
Permissive
Robust
|
Mus musculus |
GSE56098
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
Dox |
Permissive
|
Mus musculus |
GSE56098
...
|
MA0142.1
...
|
| POU5F1 |
KH2 (embryonic stem cells) |
Standard Serum |
Permissive
Robust
|
Mus musculus |
GSE56312
...
|
MA0142.1
...
|
| POU5F1 |
KH2 (embryonic stem cells) |
2i for 24 hours |
Permissive
Robust
|
Mus musculus |
GSE56312
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
Lif 2i |
Permissive
|
Mus musculus |
GSE58407
...
|
MA0142.1
...
|
| POU5F1 |
differentiated embryonic stem cells |
-Lif -2i day 1 |
Permissive
Robust
|
Mus musculus |
GSE58407
...
|
MA0142.1
...
|
| POU5F1 |
epiblast-like cells |
-Lif -2i day 3 |
Permissive
Robust
|
Mus musculus |
GSE58407
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
none |
Permissive
Robust
|
Mus musculus |
GSE59378
...
|
MA0142.1
...
|
| POU5F1 |
ES-E14 (E14, embryonic stem cells) |
shCtrl |
Permissive
Robust
|
Mus musculus |
GSE64008
...
|
MA0142.1
...
|
| POU5F1 |
ES-E14 (E14, embryonic stem cells) |
shNup153-2 |
Permissive
Robust
|
Mus musculus |
GSE64008
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cell-derived mesoderm |
none |
Permissive
|
Mus musculus |
GSE69099
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
antisense oligonucleotide |
Permissive
|
Mus musculus |
GSE69140
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
7SK antisense oligonucleotide |
Permissive
|
Mus musculus |
GSE69140
...
|
MA0142.1
...
|
| POU5F1 |
ES-E14 (E14, embryonic stem cells) |
G1 |
Permissive
Robust
|
Mus musculus |
GSE78073
...
|
MA0142.1
...
|
| POU5F1 |
ES-E14 (E14, embryonic stem cells) |
G2/M |
Permissive
Robust
|
Mus musculus |
GSE78073
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
PARP-1 KO |
Permissive
Robust
|
Mus musculus |
GSE74112
...
|
MA0142.1
...
|
| POU5F1 |
epiblast stem cells |
feeder free |
Permissive
Robust
|
Mus musculus |
GSE74636
...
|
MA0142.1
...
|
| POU5F1 |
embryoid body |
+12hrDox(iFlag.Ngn2) |
Permissive
Robust
|
Mus musculus |
GSE80321
...
|
MA0142.1
...
|
| POU5F1 |
embryoid body |
(iNgn2.Isl1.Lhx3.V5) |
Permissive
Robust
|
Mus musculus |
GSE80321
...
|
MA0142.1
...
|
| POU5F1 |
embryoid body |
+12hrDox(iNgn2.Isl1.Lhx3.V5) |
Permissive
Robust
|
Mus musculus |
GSE80321
...
|
MA0142.1
...
|
| POU5F1 |
ZHBTc4 (embryonic stem cells) |
untreated control |
Permissive
Robust
|
Mus musculus |
GSE87820
...
|
MA0142.1
...
|
| POU5F1 |
ZHBTc4 (embryonic stem cells) |
doxycycline-treated |
Permissive
|
Mus musculus |
GSE87820
...
|
MA0142.1
...
|
| POU5F1 |
Brg1fl/fl (embryonic stem cells) |
untreated control |
Permissive
Robust
|
Mus musculus |
GSE87820
...
|
MA0142.1
...
|
| POU5F1 |
Brg1fl/fl (embryonic stem cells) |
tamoxifen-treated |
Permissive
Robust
|
Mus musculus |
GSE87820
...
|
MA0142.1
...
|
| POU5F1 |
E3.5 embryonic stem cells |
asynchronous cell cycle |
Permissive
Robust
|
Mus musculus |
GSE92846
...
|
MA0142.1
...
|
| POU5F1 |
F9 (embryonal carcinoma) |
Treated with retinoic acid; Differentiated into primitive endoderm-like cells |
Permissive
|
Mus musculus |
GSE43275
...
|
MA0142.1
...
|
| POU5F1 |
KH2 (embryonic stem cells) |
Overexpress Sox17-V5 tagged |
Permissive
Robust
|
Mus musculus |
GSE43275
...
|
MA0142.1
...
|
| POU5F1 |
KH2 (embryonic stem cells) |
Overexpress Sox2-V5 tagged |
Permissive
Robust
|
Mus musculus |
GSE43275
...
|
MA0142.1
...
|
| POU5F1 |
KH2 (embryonic stem cells) |
Overexpress Sox2KE-V5 tagged; Sox2KE |
Permissive
|
Mus musculus |
GSE43275
...
|
MA0142.1
...
|
| POU5F1 |
KH2 (embryonic stem cells) |
Overexpress Sox17EK-V5 tagged; Sox17EK |
Permissive
Robust
|
Mus musculus |
GSE43275
...
|
MA0142.1
...
|
| POU5F1 |
WA09 (embryonic stem cells) |
Treatment: under normal conditions |
Permissive
Robust
|
Homo sapiens |
GSE105028
...
|
MA0142.1
...
|
| POU5F1 |
WA09 (embryonic stem cells) |
Treatment: under heat shock conditions |
Permissive
Robust
|
Homo sapiens |
GSE105028
...
|
MA0142.1
...
|
| POU5F1 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2 and Klf4 addition for 5 days Passage: 8 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| POU5F1 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2-VP16 (strong activator) and Klf4 addition for 5 days Passage: 8 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| POU5F1 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 |
Permissive
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| POU5F1 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| POU5F1 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| POU5F1 |
iPSC (induced pluripotent stem cells) |
Treatment: iPS protocol 3s2 Passage: 20 |
Permissive
Robust
|
Homo sapiens |
GSE81899
...
|
MA0142.1
...
|
| POU5F1 |
BJ (fibroblasts) |
Genotype: Clonal FOXA2 doxycycline inducible cells |
Permissive
|
Homo sapiens |
GSE92491
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP |
Permissive
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming. |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming. |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP |
Permissive
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day3 cells refractory to MEF reprogramming. |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day3 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: Thy1+, day6 cells refractory to MEF reprogramming. |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, day6 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, cKIT+, day9 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: SSEA1+, sKIT+, day 12 MEF reprogramming intermediates |
Permissive
Robust
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: het-het-het Strain: rtTA3-OKSM-Oct4GFP Treatment: GFP1+, MEF derived induced pluripotent stem cells |
Permissive
|
Mus musculus |
GSE101905
...
|
MA0142.1
...
|
| POU5F1 |
Secondary MEF cells |
Treatment: DOX induction, day1 Genotype: Mbd3f/- cell line |
Permissive
Robust
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
Secondary MEF cells |
Treatment: DOX induction, day 2 Genotype: Mbd3f/- cell line |
Permissive
Robust
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day3 Genotype: Mbd3f/- cell line |
Permissive
Robust
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day4 Genotype: Mbd3f/- cell line |
Permissive
Robust
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day5 Genotype: Mbd3f/- cell line |
Permissive
Robust
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day6 Genotype: Mbd3f/- cell line |
Permissive
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day7 Genotype: Mbd3f/- cell line |
Permissive
Robust
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
Secondary MEF cells |
Treatment: DOX induction, N2B27 2i\\LIF medium, day8 Genotype: Mbd3f/- cell line |
Permissive
Robust
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
V6.5 (embryonic stem cells) |
Genotype: Mbd3f/- cell line |
Permissive
Robust
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
MEF-1 (mouse embryonic fibroblasts) |
Genotype: MBD3flox/- Treatment: DOX inducible OSKM reprogramming Title: reanalyzed for GSE49766 |
Permissive
Robust
|
Mus musculus |
GSE102517
...
|
MA0142.1
...
|
| POU5F1 |
ES-E14 (E14, embryonic stem cells) |
Uhrf1 KO |
Permissive
Robust
|
Mus musculus |
GSE113913
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
Sorted fraction: Esrrb-High |
Permissive
Robust
|
Mus musculus |
GSE118905
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
Sorted fraction: Esrrb-Medium |
Permissive
Robust
|
Mus musculus |
GSE118905
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
Sorted fraction: Esrrb-Negative |
Permissive
Robust
|
Mus musculus |
GSE118905
...
|
MA0142.1
...
|
| POU5F1 |
V6.5 (embryonic stem cells) |
Treament: dTAG-47, 100 nM for 24 hrs |
Permissive
|
Mus musculus |
GSE120459
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts |
Treatment: + 1 ug/ml doxycycline Genotype: Smad3CA expression Source: day 3 of reprogramming |
Permissive
Robust
|
Mus musculus |
GSE85177
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
|
Mus musculus |
GSE99009
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
|
Mus musculus |
GSE99009
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
|
Mus musculus |
GSE99009
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
|
Mus musculus |
GSE99009
...
|
MA0142.1
...
|
| POU5F1 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| POU5F1 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| POU5F1 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| POU5F1 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| POU5F1 |
Tg2a |
Cell type: ebryonic stem cells Treatment: FA Cell cecle: l |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| POU5F1 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| POU5F1 |
Tg2a |
Cell type: ebryonic stem cells Treatment: DSGFA Cellcycle: M |
Permissive
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| POU5F1 |
Tg2a |
Cell type: ebryonic stem cells Treatment: FA Cellcycle: M |
Permissive
Robust
|
Mus musculus |
GSE122589
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
Treatment: 0 hr treatment; Strain: C57BL/6; |
Permissive
|
Mus musculus |
GSE65192
...
|
MA1115.1
|
| POU5F1 |
HUES8 (Embryonic stem cell, blastocyst stage) |
Genotype: SOX17-GFP knockout; |
Permissive
Robust
|
Homo sapiens |
GSE109524
...
|
MA0142.1
...
|
| POU5F1 |
HUES8 (Embryonic stem cell, blastocyst stage) |
Genotype: SOX17-GFP knockout; |
Permissive
Robust
|
Homo sapiens |
GSE109524
...
|
MA0142.1
...
|
| POU5F1 |
E14TG2A (embryonic stem cells) |
Treatment: no Dox; Cell type: 44iN; Characteristic: lif +; |
Permissive
Robust
|
Mus musculus |
GSE118898
...
|
MA0142.1
...
|
| POU5F1 |
E14TG2A (embryonic stem cells) |
Treatment: 1 ug/mL of Doxycycline; Cell type: 44iN; Characteristic: lif +; |
Permissive
Robust
|
Mus musculus |
GSE118898
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
Passage: 25 days; Genotype: Overexpression OCT4; Treatment: pMSCV mediated virus; |
Permissive
Robust
|
Mus musculus |
GSE120399
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
Passage: 25 days; Genotype: Overexpression OCT4, caMKL1 blocked; Treatment: pMSCV mediated virus; |
Permissive
Robust
|
Mus musculus |
GSE120399
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
Passage: p20-30; Genotype: wildtype; Treatment: none; |
Permissive
Robust
|
Mus musculus |
GSE120399
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
Passage: p20-30; Genotype: caMKL1 blocked; Treatment: none; |
Permissive
Robust
|
Mus musculus |
GSE120399
...
|
MA0142.1
...
|
| POU5F1 |
BJ (fibroblasts) |
INDUCED |
Permissive
|
Homo sapiens |
GSE36570
|
MA1115.1
|
| POU5F1 |
WA01 (H1, human embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BMU
|
MA1115.1
|
| POU5F1 |
GM23338 |
|
Permissive
Robust
|
Homo sapiens |
ENCSR264RJX
|
MA1115.1
|
| POU5F1 |
K562 (myelogenous leukemia) |
|
Permissive
|
Homo sapiens |
ENCSR364SNE
|
MA1115.1
|
| POU5F1 |
E14TG2A (embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
ENCSR392DGA
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE11724
...
|
MA0142.1
...
|
| POU5F1 |
WA09 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE21916
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE11431
...
|
MA0142.1
...
|
| POU5F1 |
CCE (embryonic stem cells) |
|
Permissive
|
Mus musculus |
GSE22934
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE44286
...
|
MA0142.1
...
|
| POU5F1 |
CMTi-1 (embryonic stem cells) |
|
Permissive
|
Mus musculus |
GSE34483
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE43229
...
|
MA0142.1
...
|
| POU5F1 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE46130
...
|
MA0142.1
...
|
| POU5F1 |
J1 (embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE49137
...
|
MA0142.1
...
|
| POU5F1 |
J1 (embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE49137
...
|
MA0142.1
...
|
| POU5F1 |
epiblast-like cells |
|
Permissive
Robust
|
Mus musculus |
GSE56098
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE56098
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE56098
...
|
MA0142.1
...
|
| POU5F1 |
ES-E14 (E14, embryonic stem cells) |
|
Permissive
|
Mus musculus |
GSE65093
...
|
MA0142.1
...
|
| POU5F1 |
E13.5 embryonic fibroblasts |
|
Permissive
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
E13.5 embryonic fibroblasts |
|
Permissive
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
induced embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE67520
...
|
MA0142.1
...
|
| POU5F1 |
KH2 (embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE71675
...
|
MA0142.1
...
|
| POU5F1 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0142.1
...
|
| POU5F1 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0142.1
...
|
| POU5F1 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0142.1
...
|
| POU5F1 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0142.1
...
|
| POU5F1 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE74112
...
|
MA0142.1
...
|
| POU5F1 |
epiblast stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE74636
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
|
Permissive
|
Mus musculus |
GSE85062
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts expressing OSKM for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts expressing Oct4 from pMX vector for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts expressing Oct4 from inducible system for 48h |
|
Permissive
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts expressing Oct4,Klf4 from pMX vector for 48h |
|
Permissive
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts expressing Oct4,Sox2 from pMX vector for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts expressing Oct4,Sox2,Klf4 from pMX vector for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts expressing OSKM and Flag-Fra1 for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
embryonic fibroblasts expressing OSKM and Esrrb for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
pre-induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0142.1
...
|
| POU5F1 |
E3.5 embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE92846
...
|
MA0142.1
...
|
| POU5F1 |
WA09 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE99627
...
|
MA0142.1
...
|
| POU5F1 |
WA09 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE99627
...
|
MA0142.1
...
|
| POU5F1 |
F9 (embryonal carcinoma) |
|
Permissive
Robust
|
Mus musculus |
GSE43275
...
|
MA0142.1
...
|
| POU5F1 |
embryos, late blastula |
|
Permissive
|
Danio rerio |
GSE39780
...
|
MA0142.1
...
|
| POU5F1 |
embryos, 512 cell stage |
|
Permissive
|
Danio rerio |
GSE39780
...
|
MA0142.1
...
|
| POU5F1 |
WA01 (H1, human embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE100639
...
|
MA1115.1
|
| POU5F1 |
1% H1 ESCs with 99% fibroblsat |
|
Permissive
|
Homo sapiens |
GSE100639
...
|
MA0142.1
...
|
| POU5F1 |
2nd trimester human fetal testis |
|
Permissive
|
Homo sapiens |
GSE100639
...
|
MA0142.1
...
|
| POU5F1 |
ES-E14 (E14, embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE113913
...
|
MA0142.1
...
|
| POU5F1 |
hiPSC |
|
Permissive
Robust
|
Homo sapiens |
GSE56567
|
MA1115.1
|
| POU5F1 |
NCCIT (testicular embryonic carcinoma) |
SNF5 |
Permissive
|
Homo sapiens |
GSE36134
|
MA1115.1
|
| POU5F1 |
hESC-1 (Embryonic stem cells) |
NAIVE |
Permissive
Robust
|
Homo sapiens |
GSE69646
|
MA1115.1
|
| POU5F1 |
hESC-1 (Embryonic stem cells) |
PRIMED |
Permissive
Robust
|
Homo sapiens |
GSE69646
|
MA1115.1
|
| POU5F1 |
NCCIT (testicular embryonic carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE36134
|
MA1115.1
|
| POU5F1 |
WA01 (H1, human embryonic stem cells) |
3IL |
Permissive
|
Homo sapiens |
ERP004238
|
MA1115.1
|
| POU5F1 |
WA01 (H1, human embryonic stem cells) |
3IL |
Permissive
|
Homo sapiens |
ERP004238
|
MA1115.1
|
